Shigenori Furukawa
Papers
1
Total Citations
15
H-Index
1
About
Shigenori Furukawa is a leading figure in gynecologic oncology, whose work is reshaping surgical approaches to ovarian cancer. His primary research focuses on the comparative effectiveness and safety of minimally invasive surgery (MIS) versus traditional open laparotomy, particularly for epithelial ovarian cancer. Furukawa’s most impactful contribution is a landmark 2024 systematic review and meta-analysis, which synthesized global evidence to demonstrate that MIS can achieve comparable oncologic outcomes with significantly reduced perioperative morbidity. This work, already cited 15 times, provides crucial data for surgeons debating the optimal approach for patients, challenging long-held assumptions about the necessity of open surgery. Beyond this core meta-analysis, his research portfolio explores surgical techniques, patient selection criteria, and long-term survival metrics, aiming to refine treatment protocols and improve quality of life. Furukawa’s rigorous methodology and clear, evidence-based conclusions have established him as a trusted voice in the field, guiding clinical practice and inspiring further prospective trials. His dedication to translating complex surgical data into actionable insights makes him a vital resource for trainees and established oncologists alike.
Research Focus
Key Achievements
Top Papers
- 1